Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Role of FDG-PET in Patients With Follicular Lymphoma at Time of Relapse/Progression

NCT03525665 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT03525665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Role of FDG-PET in Patients With Follicular Lymphoma at Time of Relapse/Progression
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
December 30, 2019
Enrollment
175 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma